Pfizer Inc.PFENYSE
Loading
PFE Revenue Growth (YoY Quarterly)•-1.16%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-1.16%
+4.8pp
-5.27%
-21.2pp
-118.10%
-96.0pp
-35.58%
-7.0pp
-508.93%
-488.1pp
-500.55%
-479.1pp
-503.34%
-482.4pp
+0.28%
-0.0pp
-0.30%
-0.5pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +21.91% | -7.82% | +10.31% | -5.92% | -1.16% |
| Gross Profit Growth | +116.86% | -6.39% | +14.28% | +15.89% | -5.27% |
| EBITDA Growth | +0.00% | -15.00% | +121.33% | -22.13% | -118.10% |
| Operating Income Growth | +0.00% | +1.43% | +90.26% | -28.54% | -35.58% |
| Net Income Growth | +0.00% | -4.90% | +12025.00% | -20.84% | -508.93% |
| EPS Growth | +0.00% | -5.20% | +12042.86% | -21.45% | -500.55% |
| EPS Diluted Growth | +0.00% | -5.13% | +12042.86% | -20.92% | -503.34% |
| Weighted Average Shares Growth | +0.35% | +0.32% | +0.34% | +0.32% | +0.28% |
| Weighted Average Shares Diluted Growth | +0.99% | +0.23% | +0.18% | +0.16% | -0.30% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +28.26% | +114.22% | +0.00% | -31.44% | -20.43% |
| Free Cash Flow Growth | +38.32% | +358.81% | +0.00% | -34.01% | -22.42% |
| Receivables Growth | -4.93% | +0.00% | -19.94% | -19.41% | -100.00% |
| Inventory Growth | +6.50% | +0.00% | +1.94% | -2.16% | -100.00% |
| Asset Growth | -5.79% | +0.00% | -4.67% | -4.90% | -2.45% |
| Book Value per Share Growth | -1.26% | +0.00% | +0.80% | +0.24% | -2.23% |
| Debt Growth | -10.16% | +0.00% | -10.02% | -7.36% | +1.80% |
| R&D Expense Growth | +8.80% | -12.14% | -8.71% | +53.45% | +13.29% |
| SG&A Expenses Growth | -5.46% | -12.58% | -7.75% | -1.61% | -11.64% |
1 / 4